BioNexus Gene Lab Corp. BGLC
0.68 USD -0.05 (-7.29%)
Regular-session close
0.68 0.00 0.00%
After hours · Nov 19, 4:00 PM ET
0.6586 Day range 0.753
0.6586 52-week range 4.97
- YTD
- -82.78%
- 1 year
- -85.80%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 7.42M | 9.51M | 9.77M | 10.93M | 13.36M | |
| 1.09M | 1.29M | 1.33M | 1.26M | 2.27M | |
| -3.40M | -3.65M | -3.08M | -470.46K | 989.34K | |
| -2.98M | -1.60M | -2.63M | -355.97K | 751.57K | |
| -1.61 | -0.897 | -1.66 | -0.46 | 0.48 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 2.38M | 1.58M | 2.62M | 611.85K | 578.51K | |
| 9.25M | 10.43M | 11.40M | 8.74M | 9.57M | |
| 637.86K | 2.11M | 1.74M | 2.08M | 2.39M | |
| 225.53K | 227.73K | 146.59K | 56.77K | 76.95K | |
| 8.61M | 8.32M | 9.66M | 6.67M | 7.18M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -1.84M | -2.09M | -1.82M | 551.82K | 9.16K | |
| 944.75K | 418.20K | -1.79M | -450.50K | -490.57K | |
| 298.84K | 3.98K | 6.27M | 108.17K | -28.22K | |
| -36.97K | -226.99K | -149.40K | -54.17K | -3.16K | |
| -400.58K | -1.63M | 2.40M | -5.05K | -663.77K |
